Study 23 of 38NAD+ (Nicotinamide Adenine Dinucleotide) literatureCell metabolismTop journal2026
Dual targeting of SLC25A51 and succinate dehydrogenase selectively depletes mitochondrial NAD(+) to eradicate KRAS-driven AML.
Not reported in abstract.
Where it sits
this study against the rest of the nad+ (nicotinamide adenine dinucleotide) corpus17
Preclinical · this one
16
Observational
0
Open-label
1
Randomised
4
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Limitations
Not reported in abstract.
Elsewhere in the NAD+ (Nicotinamide Adenine Dinucleotide) corpus
CLong-term NMN treatment increases lifespan and healthspan in mice in a sex dependent mannerbiorxiv-preprint · 8.5% increase in median lifespan in female mice.AnimalCThe mitochondrial deacetylase SIRT3 is nonessential for cyclophilin D-dependent procoagulant platelet formation in mice.Platelets · 2026 · Not reported in abstract.AnimalDA comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect.Journal of enzyme inhibition and medicinal chemistry · 2026 · 31 of 46 FDA-approved drugs in 2025 were small molecule drugs.reviewCNicotinamide-derived tumor-targeting carbon dots for Cancer Photothermal therapy.Journal of colloid and interface science · 2026 · Binding energy of NAM-CDs to Ki67 was -7.7 kcal/mol.AnimalCMitochondrial-targeted nano-enhancer driving a self-amplifying NAD<sup>+</sup> feedback loop to reprogram MSC spheroids metabolism for accelerated bone regeneration.Biomaterials · 2026In vitroDPyridoxal photoenzymes for asymmetric radical-radical cross-couplings.Nature · 2026—